High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study

While breast cancer prognoses are generally good, different molecular subtypes are known to have varying outcomes. Previous studies using breast cancer registries have suggested that high parity may be an adverse prognostic factor in luminal breast cancer, but breast cancer subtype definitions have...

Descripción completa

Detalles Bibliográficos
Autores principales: Jääskeläinen, Anniina, Roininen, Nelli, Karihtala, Peeter, Jukkola, Arja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457016/
https://www.ncbi.nlm.nih.gov/pubmed/32923400
http://dx.doi.org/10.3389/fonc.2020.01470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457016/
https://www.ncbi.nlm.nih.gov/pubmed/32923400
http://dx.doi.org/10.3389/fonc.2020.01470

Ejemplares similares